Karl Petri

859 total citations · 1 hit paper
14 papers, 528 citations indexed

About

Karl Petri is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Karl Petri has authored 14 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Genetics and 2 papers in Oncology. Recurrent topics in Karl Petri's work include CRISPR and Genetic Engineering (12 papers), Virus-based gene therapy research (4 papers) and RNA regulation and disease (3 papers). Karl Petri is often cited by papers focused on CRISPR and Genetic Engineering (12 papers), Virus-based gene therapy research (4 papers) and RNA regulation and disease (3 papers). Karl Petri collaborates with scholars based in United States, Germany and United Kingdom. Karl Petri's co-authors include J. Keith Joung, Luca Pinello, Jonathan Y. Hsu, Julian Grünewald, Vikram Pattanayak, Weiting Zhang, Junyan Ma, Jing-Ruey Joanna Yeh, Daniel Y. Kim and Andrew V. Anzalone and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Nature Biotechnology.

In The Last Decade

Karl Petri

13 papers receiving 515 citations

Hit Papers

CRISPR prime editing with ribonucleoprotein complexes in ... 2021 2026 2022 2024 2021 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karl Petri United States 10 485 165 56 54 33 14 528
You Kyeong Jeong South Korea 8 580 1.2× 136 0.8× 64 1.1× 28 0.5× 49 1.5× 11 599
Purnima Ravisankar United States 6 722 1.5× 202 1.2× 89 1.6× 47 0.9× 47 1.4× 6 768
Katelynn R. Kazane United States 7 552 1.1× 135 0.8× 51 0.9× 51 0.9× 64 1.9× 9 596
Alvin Hsu United States 6 691 1.4× 192 1.2× 91 1.6× 44 0.8× 42 1.3× 8 744
Kelcee A. Everette United States 5 736 1.5× 231 1.4× 91 1.6× 44 0.8× 58 1.8× 7 789
Grégoire Cullot France 5 389 0.8× 108 0.7× 31 0.6× 40 0.7× 40 1.2× 10 418
Jianhang Yin China 10 509 1.0× 125 0.8× 77 1.4× 44 0.8× 69 2.1× 12 545
Meirui An United States 5 824 1.7× 255 1.5× 88 1.6× 42 0.8× 64 1.9× 6 883
Cidi Chen United States 4 491 1.0× 155 0.9× 66 1.2× 29 0.5× 36 1.1× 7 516
Do Yon Kim South Korea 5 605 1.2× 132 0.8× 79 1.4× 25 0.5× 87 2.6× 7 636

Countries citing papers authored by Karl Petri

Since Specialization
Citations

This map shows the geographic impact of Karl Petri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Petri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Petri more than expected).

Fields of papers citing papers by Karl Petri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl Petri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Petri. The network helps show where Karl Petri may publish in the future.

Co-authorship network of co-authors of Karl Petri

This figure shows the co-authorship network connecting the top 25 collaborators of Karl Petri. A scholar is included among the top collaborators of Karl Petri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl Petri. Karl Petri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Petri, Karl, Elvira D’Ippolito, Annette Künkele, et al.. (2025). Next-generation T cell immunotherapies engineered with CRISPR base and prime editing: challenges and opportunities. Nature Reviews Clinical Oncology. 22(12). 902–923.
2.
Zhang, Weiting, Karl Petri, Junyan Ma, et al.. (2024). Enhancing CRISPR prime editing by reducing misfolded pegRNA interactions. eLife. 12. 14 indexed citations
3.
Zhang, Weiting, Karl Petri, Junyan Ma, et al.. (2023). Enhancing CRISPR prime editing by reducing misfolded pegRNA interactions. eLife. 12. 14 indexed citations
4.
Petri, Karl & Julian Grünewald. (2023). An update on prime editing: recent advances and applications. Cell and Gene Therapy Insights. 9(9). 1359–1365. 2 indexed citations
5.
Fayad, Sarah M., Daniel Y. Kim, Karl Petri, et al.. (2022). CRISPR-Cas9 treatment partially restores amyloid-β 42/40 in human fibroblasts with the Alzheimer’s disease PSEN1 M146L mutation. Molecular Therapy — Nucleic Acids. 28. 450–461. 28 indexed citations
6.
Grünewald, Julian, et al.. (2022). Engineered CRISPR prime editors with compact, untethered reverse transcriptases. Nature Biotechnology. 41(3). 337–343. 63 indexed citations
7.
Garrood, William T., Nace Kranjc, Karl Petri, et al.. (2021). Analysis of off-target effects in CRISPR-based gene drives in the human malaria mosquito. Proceedings of the National Academy of Sciences. 118(22). 23 indexed citations
8.
Annas, George J., Chase L. Beisel, Kendell Clement, et al.. (2021). A Code of Ethics for Gene Drive Research. The CRISPR Journal. 4(1). 19–24. 29 indexed citations
9.
Hsu, Jonathan Y., Julian Grünewald, Andrew V. Anzalone, et al.. (2021). PrimeDesign software for rapid and simplified design of prime editing guide RNAs. Nature Communications. 12(1). 1034–1034. 130 indexed citations
10.
Petri, Karl, Weiting Zhang, Junyan Ma, et al.. (2021). CRISPR prime editing with ribonucleoprotein complexes in zebrafish and primary human cells. Nature Biotechnology. 40(2). 189–193. 150 indexed citations breakdown →
11.
Petri, Karl & Vikram Pattanayak. (2018). SHERLOCK and DETECTR Open a New Frontier in Molecular Diagnostics. The CRISPR Journal. 1(3). 209–211. 24 indexed citations
12.
Knipping, Friederike, Mark J. Osborn, Karl Petri, et al.. (2017). Genome-wide Specificity of Highly Efficient TALENs and CRISPR/Cas9 for T Cell Receptor Modification. Molecular Therapy — Methods & Clinical Development. 4. 213–224. 36 indexed citations
13.
Petri, Karl, Richard Gabriel, Raffaele Fronza, et al.. (2015). Presence of a trs -Like Motif Promotes Rep-Mediated Wild-Type Adeno-Associated Virus Type 2 Integration. Journal of Virology. 89(14). 7428–7432. 8 indexed citations
14.
Petri, Karl, Raffaele Fronza, Richard Gabriel, et al.. (2014). Comparative Next-Generation Sequencing of Adeno-Associated Virus Inverted Terminal Repeats. BioTechniques. 56(5). 269–273. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026